Skip to main content

Global Orthopedic Biomaterial Market Size to Reach USD 42.43 Billion in 2032 | Emergen Research

Growing demand for biomaterials in knee reconstruction/replacement surgery is a key factor driving global orthopedic biomaterial market growth

Vancouver, Nov. 01, 2023 (GLOBE NEWSWIRE) — The global orthopedic biomaterial market size is expected to reach USD 42.43 Billion at a steady CAGR of 9.4% in 2032, according to latest analysis by Emergen Research. Steady revenue growth of the orthopedic biomaterial market can be attributed to rising prevalence of skeletal disorders and defects due to trauma, infections, cancers, and inflammatory and degenerative conditions.

Also, increase in life expectancy is a major contributor to the number of people suffering from skeletal disorders as decreasing regenerative capability and density of bones with growing age. Bone disorders, including fractures and osteoporosis, require treatments involving biomaterials for tissue regeneration and as scaffolds and bone substitutes. Market players are making increasing investments in research and development of biomaterial scaffolds made from polymers and bioceramics to support bone tissue growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/589

Growing demand for biomaterials in knee reconstruction/replacement surgery is driving growth of the orthopedic biomaterial market growth to a significant extent. Osteoarthritis is a commonly occurring degenerative bone disease. The occurrence of symptomatic knee osteoarthritis in men aged 60 years and above is around 10% in men, whereas it is 13% in women. Also, the number of individuals affected with symptomatic osteoarthritis is estimated to increase with the growing age and the obesity epidemic, thus propelling growth of the orthopedic biomaterial market.

Scope of Research

Report DetailsOutcome
Market size in 2020USD 14.39 Billion
CAGR (2023–2032)9.4%
Revenue forecast in 2032USD 42.43 Billion
Base year for estimation2020
Historical data2017–2019
Forecast period2023–2032
Quantitative unitsRevenue in USD Billion and CAGR in % from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredMaterial type, application, end-use, and region
Regional scopeNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scopeU.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Sweden, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, South Africa, Israel
Key companies profiledEvonik Industries AG, Zimmer Biomet, Matexcel, Globus Medical, Stryker Corporation, DSM Biomedical, Invibio Ltd., CAM Bioceramics BV, DePuy Synthes, and ExaTech Inc.
Customization scope10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/589

MAJOR COMPANIES and Competitive Landscape

The global orthopedic biomaterial market is moderately fragmented, with a number of small- and medium-sized companies accounting for a major revenue share. Major companies have well-established facilities and enter in acquisitions and mergers, and strategic agreements, and engage in various research and development activities and initiatives to develop and deploy new and more efficient technologies and products in the orthopedic biomaterial market. Some prominent players operating in the orthopedic biomaterial market are:

  • Evonik Industries AG
  • Zimmer Biomet
  • Matexcel
  • Globus Medical
  • Stryker Corporation
  • DSM Biomedical
  • Invibio Ltd.
  • CAM Bioceramics BV
  • DePuy Synthes
  • ExaTech Inc.

Strategic Development

  • In March 2020, Evonik Industries AG made an announcement about the development of an innovative osteoconductive PEEK biomaterial, which may be used to enhance bone fusion with an implant.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/589

Some Key Highlights in the Report

  • In November 2020, Olympus Corporation made an announcement about the acquisition of FH ORTHO SAS, which is a company providing solutions for orthopedic surgery. The acquisition is intended to provide a strong foothold to Olympus Corporation in orthopedic minimally invasive surgery.
  • Metals find extensive use as orthopedic biomaterials due to their exceptional mechanical and thermal conductivity properties and are used for load-bearing applications by providing adequate fatigue strength to bear the rigors of everyday activity. Presently, metallic biomaterials comprise 316L stainless steel, titanium-based alloys, cobalt-chromium alloys, and various other metals, such as gold and tantalum. In addition, the metallic properties can be altered during manufacturing processes and in a more adaptable way than ceramic and polymer biomaterials.
  • Bones and joints are the major constituents of the musculoskeletal system. Orthopedic biomaterials used in the regeneration or replacement of bone and joints have garnered significant interest in the field of orthopedic surgery, dental surgery, and maxillofacial surgery.
  • Orthopedic biomaterial market in North America accounted for largest revenue share in 2020, attributed to high adoption of technologically advanced solutions for orthopedic disorders, rapidly increasing geriatric population, and high healthcare expenditure. In addition, presence of leading providers of orthopedic biomaterials in countries in the region is expected to continue to support market growth.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/orthopedic-biomaterial-market
Emergen Research has segmented the global orthopedic biomaterial market on the basis of material type, application, end-use, and region:

  • Material Type Outlook (Revenue, USD Billion; 2019–2032)
    • Polymers
    • Ceramics & Bioactive Glasses
    • Composites
    • Metals
    • Calcium Phosphate
  • Application Outlook (Revenue, USD Billion; 2019–2032)
    • Orthopedic Implants
    • Orthobiologics
    • Joint Reconstruction/Replacement
    • Bio-resorbable Tissue Fixation
    • Visco Supplementation
  • End-Use Outlook (Revenue, USD Billion; 2019–2032)
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Sweden
      7. BENELUX
      8. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Israel
      5. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Molecular Forensics Market By Product (Instruments, Software), By Technology (Polymerase Chain Reaction (PCR), Capillary Electrophoresis, NGS), By Application (Radioactive Toxicology, Nucleic Acid Analysis), By End User, and By Region, Forecasts to 2027

Ambulatory Device Market By Product (Infusion Systems, Monitoring Devices, Records), By Application (Drug Delivery, ECG Monitoring, Blood Glucose Monitoring, Blood Pressure Monitoring, EEG Monitoring), By End User, and By Region, Forecasts to 2027

Laparoscopy and Endoscopy Devices Market By Device Type, By Application, By End-users, Forecasts to 2027

Asthma Spacers Market, By Type (Aerochamber, Inspirease, Optichamber, and Volumatic), By Distribution Channel (Retail Pharmacy, Healthcare, and E-Commerce), By End-use, and By Region Forecast to 2030

Mobile C-Arms Market By Type (Full Size, Mini), By Application (Orthopedics & Trauma, Neurology, Cardiology, Pain Management, Gastroenterology, Oncology) and By Regions Forecasts to 2027

Forensic Technology Market By Type (Polymerase Chain Reaction, Capillary Electrophoresis, Next Generation Sequencing, Rapid DNA Analysis, Automated Liquid Handling Technology, Microarrays), By Application (Healthcare, Law Enforcement Agencies, Banking & Financial Institutions, Telecom) and By Regions Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Orthopedic Biomaterial Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-orthopedic-biomaterial-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.